Your browser doesn't support javascript.
loading
Bivalent oral cholera vaccination induces a memory B cell response to the V. cholerae O1-polysaccharide antigen in Haitian adults.
Falkard, Brie; Charles, Richelle C; Matias, Wilfredo R; Mayo-Smith, Leslie M; Jerome, J Gregory; Offord, Evan S; Xu, Peng; Kovác, Pavol; Ryan, Edward T; Qadri, Firdausi; Franke, Molly F; Ivers, Louise C; Harris, Jason B.
Affiliation
  • Falkard B; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, United States of America.
  • Charles RC; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, United States of America.
  • Matias WR; Department of Medicine, Harvard Medical School, Boston, MA, United States of America.
  • Mayo-Smith LM; Department of Medicine, Harvard Medical School, Boston, MA, United States of America.
  • Jerome JG; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States of America.
  • Offord ES; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, United States of America.
  • Xu P; Partners In Health, Boston, MA, United States of America.
  • Kovác P; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, United States of America.
  • Ryan ET; NIDDK, LBC, Section on Carbohydrates, National Institutes of Health, Bethesda, MD, United States of America.
  • Qadri F; NIDDK, LBC, Section on Carbohydrates, National Institutes of Health, Bethesda, MD, United States of America.
  • Franke MF; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, United States of America.
  • Ivers LC; Department of Medicine, Harvard Medical School, Boston, MA, United States of America.
  • Harris JB; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, United States of America.
PLoS Negl Trop Dis ; 13(1): e0007057, 2019 01.
Article in En | MEDLINE | ID: mdl-30703094
ABSTRACT
The bivalent killed whole-cell oral cholera vaccine (BivWC) is being increasingly used to prevent cholera. The presence of O-antigen-specific memory B cells (MBC) has been associated with protective immunity against cholera, yet MBC responses have not been evaluated after BivWC vaccination. To address this knowledge gap, we measured V. cholerae O1-antigen MBC responses following BivWC vaccination. Adults in St. Marc, Haiti, received 2 doses of the BivWC vaccine, Shanchol, two weeks apart. Participants were invited to return at days 7, 21, 44, 90, 180 and 360 after the initial vaccination. Serum antibody and MBC responses were assessed at each time-point before and following vaccination. We observed that vaccination with BivWC resulted in significant O-antigen specific MBC responses to both Ogawa and Inaba serotypes that were detected by day 21 and remained significantly elevated over baseline for up to 12 months following vaccination. The BivWC oral cholera vaccine induces durable MBC responses to the V. cholerae O1-antigen. This suggests that long-term protection observed following vaccination with BivWC could be mediated or maintained by MBC responses.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Vibrio cholerae / Cholera Vaccines / B-Lymphocytes / Cholera / Vaccination / O Antigens Limits: Adult / Female / Humans / Male Country/Region as subject: Caribe / Haiti Language: En Journal: PLoS Negl Trop Dis Journal subject: MEDICINA TROPICAL Year: 2019 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Vibrio cholerae / Cholera Vaccines / B-Lymphocytes / Cholera / Vaccination / O Antigens Limits: Adult / Female / Humans / Male Country/Region as subject: Caribe / Haiti Language: En Journal: PLoS Negl Trop Dis Journal subject: MEDICINA TROPICAL Year: 2019 Type: Article Affiliation country: United States